Kathmere Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Buy |
+1,663
| New | +$209K | 0.02% | 444 |
|
|
2024
Q1 | – | Sell |
-820
| Closed | -$212K | – | 319 |
|
|
2023
Q4 | $212K | Sell |
820
-87
| -10% | -$22.5K | 0.03% | 268 |
|
|
2023
Q3 | $233K | Hold |
907
| – | – | 0.03% | 228 |
|
|
2023
Q2 | $258K | Buy |
+907
| New | +$258K | 0.04% | 191 |
|
|
2021
Q1 | – | Sell |
-362
| Closed | -$89K | – | 157 |
|
|
2020
Q4 | $89K | Hold |
362
| – | – | 0.02% | 201 |
|
|
2020
Q3 | $103K | Buy |
+362
| New | +$103K | 0.03% | 176 |
|
|
2020
Q1 | – | Sell |
-921
| Closed | -$273K | – | 86 |
|
|
2019
Q4 | $273K | Buy |
+921
| New | +$273K | 0.1% | 81 |
|